News Column

DIRECTOR DEALINGS: Hikma Pharmaceuticals Chairman Exercises Options

May 29, 2014

Arvind Bhunjun



LONDON (Alliance News) - Hikma Pharmaceuticals PLC Thursday said Chairman Said Darwazah exercised options over 75,924 shares at no cost under a company share plan Thursday.


Following this transaction, Darwazah has a total holding of 11 million shares, which represents 5.51% stake in the firm.


Shares in the pharmaceutical company were trading 1.1% higher at 1,702.00 pence Thursday morning.







For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Alliance News


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters